Trials / Conditions / Transthyretin Amyloid Cardiomyopathy

Transthyretin Amyloid Cardiomyopathy

19 registered clinical trials studyying Transthyretin Amyloid Cardiomyopathy — 7 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Research Study to Look at the Distribution and Effects of Coramitug on Amyloid Deposits in Heart Tissue Usin NCT07448623	Novo Nordisk A/S	Phase 1
Recruiting	A Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyret NCT07298044	Bayer	Phase 4
Not Yet Recruiting	Cardiac Amyloidosis in Patients With Aortic Stenosis NCT07170306	Shanghai Zhongshan Hospital	—
Recruiting	Early Diagnosis of Age-Linked CArdiac TransThyRetin Amyloidosis by Selective Screening in Spinal Stenosis Surg NCT06101108	Philippe Debonnaire	—
Recruiting	FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases NCT06539169	xCures	—
Recruiting	Dobutamine Stress Echocardiography in LF/LG Aortic Stenosis and Wild-type Transthyretin Amyloid Cardiomyopathy NCT06372301	Steen Hvitfeldt Poulsen	N/A
Completed	A Study to Learn About Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in India NCT06086353	Pfizer	—
Completed	A Study to Learn About the Study Medicine Called Tafamidis 61mg in People Diagnosed With Transthyretin Amyloid NCT06321523	Pfizer	—
Recruiting	Phenotyping and Characterization of wtATTR-CM (TRACE 1) NCT06291805	Steen Hvitfeldt Poulsen	—
Active Not Recruiting	Study of ALXN2220 Versus Placebo in Adults With ATTR-CM NCT06183931	Alexion Pharmaceuticals, Inc.	Phase 3
Active Not Recruiting	EPIC-ATTR: A Study to Evaluate the Effect of Eplontersen on the Transthyretin Reduction and Long-term Safety i NCT06194825	AstraZeneca	Phase 3
Active Not Recruiting	Bronx Transthyretin Amyloid Cardiomyopathy Database NCT06257485	Montefiore Medical Center	—
Completed	Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis NCT04899180	Mayo Clinic	EARLY_Phase 1
Unknown	Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Re NCT05896904	Aarhus University Hospital Skejby	N/A
Completed	SGLT2 Inhibitors in Transthyretin Amyloid Cardiomyopathy NCT05233163	Columbia University	Phase 4
Terminated	carDIo-ttranSSfOrm nucLEar Imaging Study NCT05259072	Oregon Health and Science University	—
Unknown	Artificial Intelligence to Assist the Echocardiographic Identification of Transthyretin Cardiac Amyloidosis NCT06328075	Algalarrondo Vincent	—
Completed	A Study to Assess the Safety and Efficacy Of Tafamidis In Chinese Participants With Transthyretin Amyloid Card NCT04814186	Pfizer	Phase 4
Terminated	Global Prevalence of ATTR-CM in Participants With HFpEF NCT04424914	Pfizer	N/A